This is an audio version of the Wikipedia Article:
Mometasone for montréal is a combination inhaler containing both an inhaled corticosteroid and long-acting bronchodilator it is indicated for the maintenance treatment of asthma in adults and children twelve years of age and older whose asthma is not well controlled on low or medium dose corticosteroids or whose disease clearly warrants combination therapy it
Is not approved for the treatment of acute bronchospasm to relieve acute symptoms a rapid onset short duration inhaled bronchodilators such as salbutamol should be available to the patient for use it consists of two medications supplied in a single inhaler for montréal fumarate dihydrate a long-acting beta to adreno receptor agonist bronchodilator mo medicine
408 an inhaled corticosteroid anti-inflammatory the safety and efficacy of this medication in children less than 12 years of age has not been established it is marketed by merck & co in canada and russia as zhen hale and in the united states as de lara and is supplied as a metered dose inhaler warnings and precautions long-acting beta adreno receptor agonist
Lavas are subject to a boxed warning against the possibility of an increased risk of asthma related death for montréal belongs to the lavich class of drugs as there does not exist at the time of the monographs publication adequate research to determine whether the rate of asthma related death is increased with four montréal it is therefore recommended by the fda
That lavaz only be used for patients not adequately controlled on other asthma controlling medications or whose disease severity clearly warrants initiation of dual therapy side-effects the most commonly reported side effects were oral thrush nausea headache and pain in the pharynx or larynx more rarely reported side effects occurring in-house applied in dosage
Mo medicine for montréal is available in a pressurized mdi p mdi in three strengths in micrograms of mometasone micrograms of four mater all 50 v s– 105th and 200 v the following is the manufacturer’s recommended dose based on prior asthma therapy inhaled low-dose corticosteroids 50 v to inhalations twice daily to a maximum of 200 twentieths of a microgram daily
Inhaled medium dose corticosteroids 152 inhalations twice daily to a maximum of 400 twentieths of a microgram daily inhaled high-dose corticosteroids 250 to inhalations twice daily to a maximum of 800 twentieths of a microgram daily market zen hale was approved in canada in early 2011 talero was approved by the food and drug administration fda in the united states
In june 2010 zen hales marketing application was voluntarily withdrawn from the eu due to the manufacturers inability to provide additional information in the necessary time frame references external links official website
Transcribed from video
Mometasone/formoterol | Wikipedia audio article By wikipedia tts
